STC1 and neoplasm: Recent work also indicated that STC1 is a novel immune checkpoint that inhibits the phagocytosis of dying tumor cells by antigen-presenting cells and impairs the antigen-presenting capacity of antigen-presenting cells and the activation of T cells, ultimately contributing to tumor immune escape and tumor growth [33].